ClinicalTrials HQ

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

Recruiting · NCT07682896 · Registry updated 2026-10-05
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' DiseaseGraves disease, autoimmune disease, disease of orbital part of eye adnexa, endocrine system disorder, exophthalmos, eye disorder, goiter, hyperthyroidism, immune system disorder, thyroid gland disorderRecruitingPhase 22026-10-05NCT07682896

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Yarrow Bioscience, Inc.1

29 results · Page 1 of 2

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 100AmarilloUnited States1
Site 101HumbleUnited States1
Site 103SacramentoUnited States1
Site 105TorranceUnited States1
Site 106Fort WorthUnited States1
Site 107LivoniaUnited States1
Site 108OmahaUnited States1
Site 109Miami LakesUnited States1
Site 110HoustonUnited States1
Site 111San FranciscoUnited States1
Site 112GilbertUnited States1
Site 115Palm HarborUnited States1
Site 117ConroeUnited States1
Site 118MaconUnited States1
Site 120Orchard ParkUnited States1
Site 121La MesaUnited States1
Site 122Bowling GreenUnited States1
Site 123SarasotaUnited States1
Site 124SayreUnited States1
Site 126FlintUnited States1
Site 127El PasoUnited States1
Site 128EdinburgUnited States1
Site 129Niagara FallsUnited States1
Site 130PhoenixUnited States1
Site 131CaryUnited States1